Patents by Inventor Naho IKARI

Naho IKARI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11518976
    Abstract: An object of the present invention is to provide a method for efficiently obtaining a lactic acid bacterium that is made to contain a large amount of double-stranded RNA; and a lactic acid bacterium having a high double-stranded RNA content obtained by the method. The object is achieved by: (1) a method for producing a double-stranded RNA-containing lactic acid bacterium, including a step of culturing a lactic acid bacterium under at least one condition of an aeration condition and a low-temperature condition lower than an optimum temperature, thereby obtaining the double-stranded RNA-containing lactic acid bacterium; (2) a double-stranded RNA-containing lactic acid bacterium, in which the content of double-stranded RNA is 2.0 times or more as compared with the content of double-stranded RNA when a bacterium of the same strain is cultured for the same culture time under an optimum temperature and non-aeration condition; or the like.
    Type: Grant
    Filed: May 11, 2018
    Date of Patent: December 6, 2022
    Assignee: KIKKOMAN CORPORATION
    Inventors: Tadaomi Kawashima, Naho Ikari, Hiroshi Kawamoto
  • Publication number: 20200115673
    Abstract: An object of the present invention is to provide a method for efficiently obtaining a lactic bacterium having a high double-stranded RNA content obtained by the method. The object is achieved by: (1) a method for producing a double-stranded RNA-containing lactic acid bacterium, including a step of culturing a lactic acid bacterium under at least one condition of an aeration condition and a low-temperature condition lower than an optimum temperature, thereby obtaining the double-stranded RNA-containing lactic acid bacterium; (2) a double-stranded RNA-containing lactic acid bacterium, in which the content of double-stranded RNA is 2.0 times or more as compared with the content of double stranded RNA when a bacterium of the same strain is cultured for the same culture time under an optimum temperature and non-aeration condition; or the like.
    Type: Application
    Filed: May 11, 2018
    Publication date: April 16, 2020
    Applicant: Kikkoman Corporation
    Inventors: Tadaomi KAWASHIMA, Naho IKARI, Hiroshi KAWAMOTO
  • Publication number: 20190099456
    Abstract: An object of the present invention is to provide a composition for promoting interferon ? production, which contains an active ingredient exhibiting an effect of promoting interferon ? production with respect to BDCA3 DC, and a production method therefor. The present invention relates to (1) a composition for promoting interferon ? production, which contains a bacterial cell, a bacterial component, or a culture of lactic acid bacteria capable of being cultured under stress conditions, as an active ingredient, and (2) a method for producing a composition for promoting interferon ? production, which includes culturing lactic acid bacteria capable of being cultured under stress conditions so as to obtain a bacterial cell, a bacterial component, or a culture of the lactic acid bacteria.
    Type: Application
    Filed: April 4, 2017
    Publication date: April 4, 2019
    Applicants: KIKKOMAN CORPORATION, NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE, NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY
    Inventors: Sachiyo YOSHIO, Tatsuya KANTO, Tadaomi KAWASHIMA, Naho IKARI, Noriko TSUJI